JP2019509745A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509745A5
JP2019509745A5 JP2018550782A JP2018550782A JP2019509745A5 JP 2019509745 A5 JP2019509745 A5 JP 2019509745A5 JP 2018550782 A JP2018550782 A JP 2018550782A JP 2018550782 A JP2018550782 A JP 2018550782A JP 2019509745 A5 JP2019509745 A5 JP 2019509745A5
Authority
JP
Japan
Prior art keywords
raav vector
column
vector particles
factor
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550782A
Other languages
English (en)
Japanese (ja)
Other versions
JP7364306B2 (ja
JP2019509745A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/025396 external-priority patent/WO2017173283A1/en
Publication of JP2019509745A publication Critical patent/JP2019509745A/ja
Publication of JP2019509745A5 publication Critical patent/JP2019509745A5/ja
Priority to JP2022092235A priority Critical patent/JP7659523B2/ja
Application granted granted Critical
Publication of JP7364306B2 publication Critical patent/JP7364306B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550782A 2016-03-31 2017-03-31 カラムに基づく高度にスケーラブルなrAAVの製造プロセス Active JP7364306B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022092235A JP7659523B2 (ja) 2016-03-31 2022-06-07 カラムに基づく高度にスケーラブルなrAAVの製造プロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662316252P 2016-03-31 2016-03-31
US62/316,252 2016-03-31
PCT/US2017/025396 WO2017173283A1 (en) 2016-03-31 2017-03-31 Column-based fully scalable raav manufacturing process

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022092235A Division JP7659523B2 (ja) 2016-03-31 2022-06-07 カラムに基づく高度にスケーラブルなrAAVの製造プロセス

Publications (3)

Publication Number Publication Date
JP2019509745A JP2019509745A (ja) 2019-04-11
JP2019509745A5 true JP2019509745A5 (enExample) 2020-03-26
JP7364306B2 JP7364306B2 (ja) 2023-10-18

Family

ID=59966426

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018550782A Active JP7364306B2 (ja) 2016-03-31 2017-03-31 カラムに基づく高度にスケーラブルなrAAVの製造プロセス
JP2022092235A Active JP7659523B2 (ja) 2016-03-31 2022-06-07 カラムに基づく高度にスケーラブルなrAAVの製造プロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022092235A Active JP7659523B2 (ja) 2016-03-31 2022-06-07 カラムに基づく高度にスケーラブルなrAAVの製造プロセス

Country Status (23)

Country Link
US (1) US11702639B2 (enExample)
EP (1) EP3436051B1 (enExample)
JP (2) JP7364306B2 (enExample)
KR (1) KR102405250B1 (enExample)
CN (1) CN109152821A (enExample)
AU (1) AU2017240721B2 (enExample)
CA (1) CA3019133A1 (enExample)
CL (1) CL2018002754A1 (enExample)
CO (1) CO2018011151A2 (enExample)
DK (1) DK3436051T3 (enExample)
ES (1) ES2896080T3 (enExample)
HU (1) HUE056854T2 (enExample)
IL (1) IL261970B2 (enExample)
LT (1) LT3436051T (enExample)
MY (1) MY195391A (enExample)
PE (1) PE20190434A1 (enExample)
PH (1) PH12018502104B1 (enExample)
PL (1) PL3436051T3 (enExample)
PT (1) PT3436051T (enExample)
RU (1) RU2754467C2 (enExample)
SA (1) SA518400146B1 (enExample)
SG (1) SG11201808354PA (enExample)
WO (1) WO2017173283A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3215191B1 (en) 2014-11-05 2024-08-14 Voyager Therapeutics, Inc. Aadc polynucleotides for the treatment of parkinson's disease
CN114717264A (zh) 2014-11-14 2022-07-08 沃雅戈治疗公司 治疗肌萎缩性侧索硬化(als)的组合物和方法
KR20230145206A (ko) 2014-11-14 2023-10-17 보이저 테라퓨틱스, 인크. 조절성 폴리뉴클레오티드
US11697825B2 (en) 2014-12-12 2023-07-11 Voyager Therapeutics, Inc. Compositions and methods for the production of scAAV
PH12018502104B1 (en) * 2016-03-31 2024-03-27 Spark Therapeutics Inc Column-based fully scalable raav manufacturing process
US10584337B2 (en) 2016-05-18 2020-03-10 Voyager Therapeutics, Inc. Modulatory polynucleotides
WO2018044912A1 (en) 2016-08-29 2018-03-08 Wayne State University Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
EP3658250A4 (en) * 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
EP4585229A3 (en) * 2017-11-08 2026-01-14 Novartis AG Means and method for preparing viral vectors and uses of same
WO2019209632A1 (en) * 2018-04-24 2019-10-31 Merck Sharp & Dohme Corp. Scalable chromatography process for purification of human cytomegalovirus
CN112424359A (zh) 2018-05-15 2021-02-26 沃雅戈治疗公司 用于治疗帕金森氏病的组合物和方法
JP7478675B2 (ja) 2018-06-08 2024-05-07 ノバルティス アーゲー 薬物製品の効力を測定するための細胞ベースアッセイ
US12281321B2 (en) 2018-09-28 2025-04-22 Voyager Therapeutics, Inc. Frataxin expression constructs having engineered promoters and methods of use thereof
US20220267796A1 (en) * 2019-06-28 2022-08-25 Takeda Pharmaceutical Company Limited Adeno-associated virus purification methods
WO2021207132A1 (en) * 2020-04-06 2021-10-14 Brown University Formulations and processes for treating water from impacted sources
WO2022045055A1 (ja) * 2020-08-24 2022-03-03 タカラバイオ株式会社 pHの違いによる非エンベロープウイルスベクター粒子の調製方法
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
ATE237694T1 (de) 1991-08-20 2003-05-15 Us Gov Health & Human Serv Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
US6004797A (en) 1995-11-09 1999-12-21 Avigen, Inc. Adenovirus helper-free recombinant AAV Virion production
CA2995542A1 (en) * 1997-09-05 1999-03-11 Genzyme Corporation Methods for generating high titer helper-free preparations of recombinant aav vectors
AU2001257611A1 (en) 2000-04-28 2001-11-12 Avigen, Inc. Polynucleotides for use in recombinant adeno-associated virus virion production
US6593123B1 (en) 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US7419817B2 (en) 2002-05-17 2008-09-02 The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
JP4559429B2 (ja) 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
DK2623605T3 (en) 2007-04-09 2019-03-25 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
JP5956331B2 (ja) 2009-06-16 2016-07-27 ジェンザイム・コーポレーション 組換えaavベクターの改良された精製方法
EP2325194A1 (en) * 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
EP2529020B1 (en) 2010-01-28 2018-04-25 The Children's Hospital of Philadelphia A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
WO2013050523A1 (en) * 2011-10-05 2013-04-11 Molmed Spa Viral vectors purification system
PH12018502104B1 (en) 2016-03-31 2024-03-27 Spark Therapeutics Inc Column-based fully scalable raav manufacturing process

Similar Documents

Publication Publication Date Title
JP2020526190A5 (enExample)
JP2018121653A5 (enExample)
RU2018138164A (ru) ПОЛНОСТЬЮ МАСШТАБИРУЕМЫЙ СПОСОБ ПРОИЗВОДСТВА rAAV НА ОСНОВЕ КОЛОНОК
JP2016185153A5 (enExample)
KR102669561B1 (ko) Aav 벡터 컬럼 정제 방법
KR102695908B1 (ko) 재조합 아데노-관련 바이러스(rAAV) 벡터를 고수율로 생산하기 위한 확장 가능한 고회수 방법 및 이에 의해 생산된 재조합 아데노-관련 바이러스(rAAV) 벡터
JP6991095B2 (ja) ウイルスベクター精製における拡張可能な製造プラットフォームおよび遺伝子治療における使用のための高純度ウイルスベクター
JP2024525142A (ja) Aavベクターカラム精製方法
JP2025535118A (ja) Aavカプシドの精製のためのクロマトグラフィー方法
BR112019028299B1 (pt) Método para a purificação de partículas de vetores adenoassociados recombinantes (raav)